OBJECTIVES: We examined the reliability, validity, and factor structure of the posttraumatic stress diorder (PTSD) Checklist-Civilian Version (PCL-C; Blanchard, Jones-Alexander, Buckley, & Forneris, 1996) among unselected undergraduate students. PARTICIPANTS: Participants were 471 undergraduate students at a large university in the Eastern United States and were not preselected based on trauma history or symptom severity. RESULTS: The PCL-C demonstrated good internal consistency and retest reliability. Compared with alternative measures of PTSD, the PCL-C showed favorable patterns of convergent and discriminant validity. In contrast to previous research using samples with known trauma exposure, we found support for both 1-factor and 2-factor models of PTSD symptoms. CONCLUSIONS: Overall, the PCL-C appears to be a valid and reliable measure of PTSD symptoms, even among nonclinical samples, and is superior to some alternative measures of PTSD. The factor structure among nonclinical samples may not reflect each of the PTSD symptom "clusters" (i.e., reexperiencing, avoidance/numbing, and hyperarousal).
OBJECTIVES: We examined the reliability, validity, and factor structure of the posttraumatic stress diorder (PTSD) Checklist-Civilian Version (PCL-C; Blanchard, Jones-Alexander, Buckley, & Forneris, 1996) among unselected undergraduate students. PARTICIPANTS: Participants were 471 undergraduate students at a large university in the Eastern United States and were not preselected based on trauma history or symptom severity. RESULTS: The PCL-C demonstrated good internal consistency and retest reliability. Compared with alternative measures of PTSD, the PCL-C showed favorable patterns of convergent and discriminant validity. In contrast to previous research using samples with known trauma exposure, we found support for both 1-factor and 2-factor models of PTSD symptoms. CONCLUSIONS: Overall, the PCL-C appears to be a valid and reliable measure of PTSD symptoms, even among nonclinical samples, and is superior to some alternative measures of PTSD. The factor structure among nonclinical samples may not reflect each of the PTSD symptom "clusters" (i.e., reexperiencing, avoidance/numbing, and hyperarousal).
Authors: Molly H Gardner; Sylvie Mrug; David C Schwebel; Sean Phipps; Kimberly Whelan; Avi Madan-Swain Journal: Psychooncology Date: 2015-10-22 Impact factor: 3.894
Authors: Ann M Rasmusson; Christine E Marx; Sonia Jain; Gail M Farfel; Julia Tsai; Xiaoying Sun; Thomas D Geracioti; Mark B Hamner; James Lohr; Richard Rosse; Lanier Summerall; Jennifer C Naylor; Cristine Cusin; Ariel J Lang; Rema Raman; Murray B Stein Journal: Psychopharmacology (Berl) Date: 2017-07-01 Impact factor: 4.530
Authors: Molly H Gardner; Sylvie Mrug; David C Schwebel; Sean Phipps; Kimberly Whelan; Avi Madan-Swain Journal: Cancer Nurs Date: 2017 Sep/Oct Impact factor: 2.592
Authors: Kathryn M Nowotny; Jessica Frankeberger; Victoria E Rodriguez; Avelardo Valdez; Alice Cepeda Journal: Behav Med Date: 2018-05-09 Impact factor: 3.104
Authors: Na Yang; Bizu Gelaye; Qiuyue Zhong; Marta B Rondon; Sixto E Sanchez; Michelle A Williams Journal: Arch Womens Ment Health Date: 2016-05-19 Impact factor: 3.633